KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Travere Therapeutics (TVTX) Non-Current Receivables (2016)

Travere Therapeutics' Non-Current Receivables history spans 3 years, with the latest figure at $46.2 million for Q2 2016.

  • For Q2 2016, Non-Current Receivables changed N/A year-over-year to $46.2 million; the TTM value through Jun 2016 reached $46.2 million, changed N/A, while the annual FY2015 figure was $45.6 million, N/A changed from the prior year.
  • Non-Current Receivables reached $46.2 million in Q2 2016 per TVTX's latest filing, up from $45.9 million in the prior quarter.
  • In the past five years, Non-Current Receivables ranged from a high of $46.2 million in Q2 2016 to a low of $137547.0 in Q1 2013.
  • Average Non-Current Receivables over 3 years is $36.6 million, with a median of $45.6 million recorded in 2015.